Plain-English translation of NCT06715436 on ClinicalTrials.gov ↗ ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether diet can help improve symptoms and quality of life in people with relapsing-remitting multiple sclerosis. You'll be randomly assigned to follow either a Mediterranean diet (rich in vegetables, fish, and olive oil) or a ketogenic diet (very low in carbohydrates, higher in healthy fats). The study will track how each diet affects your well-being, inflammation markers, and MS symptoms over time.
Recent research suggests that what we eat may play a role in MS progression and severity. While some studies show the Mediterranean diet may lower MS risk, there's limited evidence comparing it directly to other dietary approaches like the ketogenic diet in people already living with MS.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to follow either a Mediterranean or ketogenic diet tailored to your personal calorie and protein needs. You'll receive detailed meal guidance and meet with the study team to begin your assigned eating plan. Over the study period, you'll have monthly phone check-ins to discuss how well you're sticking to the diet, any changes in your symptoms, and adjustments as needed. The study will monitor your quality of life, MS symptoms, and how your body responds to the diet through these regular contacts.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
Italy